Hot Investor Mandate: PE Firm Invests Up to €15M in Early-Stage Biotech and Medtech Companies in Europe

20 May

A private equity firm based in Europe typically makes an initial investment of up to €2-3M, and up to €10-15M over the life of the investment, which can be start as early as Series A. The firm invests in EU-based companies.

The firm’s venture team focuses its life sciences investments on therapeutics: mainly biotech companies and opportunistically in medtech companies developing therapeutic implantable devices. The firm is agnostic in terms of subsectors, indications and stage. Currently, the firm is active in many subsectors.

The firm seeks to acquire minority stakes in its portfolio companies. The firm is looking for companies with a talented and entrepreneurial management team.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: